Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Closed-loop TIVA guided by depth-of-anesthesia monitoring (CLADS)
ChiCTR2300076310Phase 4Not yet recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Oct 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol, remimazolam, remifentanil and rocuronium (3 arms), sponsored by The Fourth Hospital of Hebei Medical University. Primary endpoint: Percentage of adequate analgesia time. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
propofolremimazolamremifentanilrocuronium
Beyond the preview
Go deeper on ChiCTR2300076310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076310.